Christina Moon, MD
Ophthalmology · Philadelphia, PANPI 1821259102
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,188 of the $1,482 with a category attached, or 80.2%. Alcon accounts for 80.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $1,089 and has fallen 79.4% since, to $224 in 2025. That places this record below the midpoint for ophthalmology clinicians in PA, where the typical reported total is $1,202.
Across 8 payments — averaging $185.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Johnson & Johnson Surgical Vision, Inc.$211
- Biotissue Holdings Inc.$83
What the payments were for
- Travel & lodging$1,18880%
- Food & beverage$29420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 2 | $1,188 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $211 |
| Biotissue Holdings Inc. | 4 | $83 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis IOL$125
How this compares
$1,482 in reported general payments places this provider in the 50th percentile of 920 ophthalmology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 75 | $60,521 |
| XiidraLifitegrast | 63 | $49,391 |
| Cyclosporine | 89 | $33,322 |
| Prednisolone Acetate | 571 | $23,231 |
| MoxifloxacinMoxifloxacin Hcl | 298 | $5,653 |
| Ketorolac Tromethamine | 311 | $4,582 |
| ValacyclovirValacyclovir Hcl | 68 | $3,672 |
| ErythromycinErythromycin Base | 63 | $935 |
| Latanoprost | 85 | $879 |
| Brimonidine Tartrate | 52 | $505 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 36 | $438 |
| Acyclovir | 27 | $380 |
| Timolol Maleate | 44 | $257 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 12 | $63 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Philadelphia
- Julia HallerPhiladelphia$1.5M
- Beeran MeghparaPhiladelphia$496K
- Jonathan MyersPhiladelphia$359K
- Mark BlecherPhiladelphia$357K
- Anton KolomeyerPhiladelphia$355K
- Durga BorkarPhiladelphia$150K
- Rachel NiknamPhiladelphia$142K
- Joseph MarkoffPhiladelphia$130K
- Leslie KatzPhiladelphia$105K
- Zeba SyedPhiladelphia$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.